OncoSignal

Andrew Lane

Dana-Farber Cancer Institute

Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.

Registry trials as an overall official
2
all conditions, ClinicalTrials.gov
NIH grants tied to them
4
20 more share only the name and are not shown
Trial papers
145
PubMed author-name match

Trials

Studies that name Andrew Lane as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 21:12 UTC. Open this list on ClinicalTrials.gov

Grants

NIH projects from RePORTER, fetched 2026-11-11 21:12 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 20 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

Most cited trial papers

Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 21:12 UTC. The ranking covers the 200 most relevant of 145 PubMed records, and a shared surname and initials can bring in a namesake. All 145 on PubMed

  1. 663 citations
    RCR 25.6
  2. 429 citations
    RCR 12.5
  3. 366 citations
    RCR 13.0
  4. 286 citations
    RCR 11.1
  5. 278 citations
    RCR 15.1
  6. 247 citations
    RCR 7.7
  7. 241 citations
    RCR 7.7
  8. 208 citations
    RCR 6.1
  9. 192 citations
    RCR 5.8
  10. 170 citations
    RCR 6.7